Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases

Proposed acquisition will enrich the AstraZeneca cell therapy pipeline with clinical-stage autologous BCMA/CD19 CAR-T therapy targeting haematologic malignancies and autoimmune diseases, and...

Related Keywords

Shanghai ,China ,United States ,Suzhou ,Jiangsu ,Cayman Islands ,American ,Susan Galbraith ,Harney Westwood Riegels ,William Cao ,Gracell Fas ,Exchange Commission ,Fierce Life Sciences Innovation ,Gracell Biotechnologies Inc ,Astrazeneca ,Freshfields Bruckhaus Deringer ,Nasdaq ,Maples Group ,American Depositary Share ,Executive Vice President ,Allbright Law Offices ,Harney Westwood ,Biotech Innovation ,Life Sciences Innovation Awards ,Overall Immunology Solution ,Biotech Breakthrough Awards ,Private Securities Litigation Reform Act ,Markets ,